A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren's Syndrome
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ghaith Noaiseh, MD
University of Pittsburgh
Principal Investigator - Maria Dall'Era, MD
University of California, San Francisco
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Brest, France
- Research Site
Le Kremlin-Bicêtre, France
- Research Site
Lille, France
- Research Site
Paris, France
- Research Site
Paris, France
- Research Site
Strasbourg, France
- Research Site
Stockholm, Sweden
- Research Site
London, United Kingdom
- Research Site
Newcastle upon Tyne, United Kingdom
- Research Site
Swindon, United Kingdom
- Research Site
San Francisco, California, United States
- Research Site
Bethesda, Maryland, United States
- Research Site
Pittsburgh, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Jun 2015
- Primary completion
- 16 Jan 2018
- Completion
- 13 Aug 2018
- Last update posted
- 19 Mar 2019
- Registered enrollment
- 32
- Registry id
- NCT02334306
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.